Research progress on the mechanism of berberine in the prevention and treatment of Parkinson’s disease
Author:
Affiliation:

1. Encephalopathy Center, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou 450000, China. 2. the First Clinical Medical College of Henan University of Traditional Chinese Medicine, Zhengzhou 450000. 3. the Third Affiliated Hospital of Zhengzhou University, Zhengzhou 450000

Clc Number:

R-33

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Parkinson’s disease(PD) is a neurodegenerative disease that primarily affects middle-aged and older adults. Its main clinical manifestations include resting tremor, bradykinesia, myotonia, and balance disorders. Berberine is a naturally occurring isoquinoline alkaloid. Several studies over the previous decade have reported that berberine plays a crucial role in the pathophysiologic processes of a range of diseases, including playing an active role in the development of PD via different pathways. This paper systematically reviews the mechanism of action of berberine in the prevention and treatment of PD and the current status of research, to provide references for the future clinical application of berberine for the treatment of PD.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:57
  • PDF: 86
  • HTML: 0
  • Cited by: 0
History
  • Received:August 11,2024
  • Online: March 05,2025
Article QR Code